Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 8393 - 8400 of 12144 results
Zen Magnets Claims “90% Victory” Against CPSC in Magnet Recall Litigation
April 15, 2016| Blog| Viewpoint
Key Lessons from Patent Litigation for Drafting and Prosecuting Utility Patent Applications
April 15, 2016| Blog| Viewpoint
A Decade Later, Rules for the Sanitary Transportation of Food Finally Finalized by FDA
April 14, 2016| Blog| Viewpoint
Article 29 Working Party Opinions on Privacy Shield and Surveillance
April 14, 2016| Blog| Viewpoint
Mintz's Health Care Enforcement Defense Group Publishes New Qui Tam Update
April 14, 2016| Blog| Viewpoint
Governor Baker Signs Controversial Solar Legislation Lifting Solar Energy Caps
April 13, 2016| Alert| Viewpoint
TRANQUIL WATERS ONCE AGAIN IN THE SAFE HARBOR: Bankruptcy Safe Harbor Protects Shareholders From State Constructive Fraud Claims
April 13, 2016| Blog| Viewpoint
Governor Baker Signs Controversial Solar Legislation
April 13, 2016| Blog| Viewpoint
News & Press Releases
Mintz Advises Point72 and Tsunami Express Car Wash in Acquisition of 53 Car Wash Locations from Whistle Express Car Wash
September 16, 2025
Mintz advised Point72 and Tsunami Express Car Wash, its portfolio company, in Tsunami’s acquisition of 53 car wash locations from Whistle Express Car Wash, which is owned by affiliates of Oaktree Capital Management.
Mintz Advises Charlesbank Capital Partners on Acquisition of Q6 Cyber
September 15, 2025
Mintz Advises on LB Pharmaceuticals’ $285 Million Initial Public Offering
September 12, 2025
Mintz advised the underwriters in connection with a $285 million initial public offering by LB Pharmaceuticals Inc of 19,000,000 shares of common stock at an initial public offering price of $15.00 per share. The aggregate gross proceeds to LB Pharmaceuticals from this offering were approximately $285 million before deducting underwriting discounts and commissions and other offering expenses. In addition, LB Pharmaceuticals granted the underwriters a 30-day option to purchase up to an additional 2,850,000 shares of common stock at the initial public offering price, less underwriting discounts and commissions. The shares began trading on the Nasdaq Global Market on September 11, 2025 under the ticker symbol “LBRX.”
Events
Podcasts
Mintz On Air: Practical Policies – DEI Developments: The Proxy Problem
September 16, 2025| Podcast|
Mintz On Air: Practical Policies – Disparage Me Not
August 26, 2025| Podcast|
Mintz On Air: Practical Policies - Investigations Unscripted
August 12, 2025| Podcast|